Strongyloides stercoralis and other intestinal parasites in patients receiving immunosuppressive drugs in northern Iran: a closer look at risk factors

The objective of this study was to evaluate the prevalence of Strongyloides stercoralis and other intestinal parasites in patients receiving immunosuppressive drugs in northern Iran and to investigate related risk factors. This cross-sectional study was conducted among 494 patients receiving immunos...

Full description

Saved in:
Bibliographic Details
Published in:Epidemiology and health 2021, Vol.43, p.e2021009-e2021009
Main Authors: Mirzaei, Leila, Ashrafi, Keyhan, Atrkar Roushan, Zahra, Mahmoudi, Mohammad Reza, Shenavar Masooleh, Irandokht, Rahmati, Behnaz, Saadat, Farshid, Mirjalali, Hamed, Sharifdini, Meysam
Format: Article
Language:English
Subjects:
Adult
Animals
Cross-Sectional Studies
Feces - parasitology
Female
Humans
immunocompromised patients
Immunosuppressive Agents - therapeutic use
Intestinal Diseases, Parasitic - epidemiology
iran
Iran - epidemiology
Male
Middle Aged
Original
Prevalence
Risk Factors
Strongyloides stercoralis - isolation & purification
strongyloidiasis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The objective of this study was to evaluate the prevalence of Strongyloides stercoralis and other intestinal parasites in patients receiving immunosuppressive drugs in northern Iran and to investigate related risk factors. This cross-sectional study was conducted among 494 patients receiving immunosuppressive drugs, including cancer patients undergoing chemotherapy (n=188) and those treated with prolonged corticosteroid administration (n=306). All fresh fecal samples were examined using the direct wet-mount, formalin ethyl acetate concentration, and agar plate culture techniques. In total, 16.8% of patients were positive for at least 1 intestinal parasite; the helminthic and protozoan infection rates were 5.1% and 12.3%, respectively. The infection rate was significantly higher in corticosteroid-treated individuals (19.6%) than cancer patients (12.2%) (p
ISSN:2092-7193
2092-7193
DOI:10.4178/epih.e2021009